Related Experiment Videos
[Sodium valproate--still a current antiepileptic agent?]
G Scollo-Lavizzari1, D Proeckl
1Abteilung für Elektroenzephalographie und Anfallsambulanz, Kantonsspital Basel.
Praxis
|October 4, 1994
Summary
Valproate has been an anticonvulsant in Switzerland for 25 years. This review synthesizes current knowledge on its use, covering mechanism, efficacy, and safety.
Area of Science:
- Pharmacology
- Neurology
- Clinical Medicine
Context:
- Valproate has been utilized as an anticonvulsant medication in Switzerland for a quarter-century.
- This review synthesizes current knowledge on valproate's therapeutic applications.
Purpose:
- To provide a comprehensive overview of valproate's scientific and clinical profile.
- To consolidate information on its mechanism, pharmacokinetics, efficacy, and safety.
Summary:
- The review details valproate's mechanism of action, pharmacokinetic properties, and clinical effectiveness in seizure management.
- It also addresses adverse effects, potential drug interactions, and administration guidelines for specific patient populations.
Impact:
- This synopsis serves as a valuable resource for healthcare professionals managing epilepsy and other conditions treated with valproate.
- It aids in optimizing patient care through informed decision-making regarding valproate therapy.